PharmaCielo Ltd.
PCLO.V
TSX
| 06/30/2025 | 09/30/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -940.30K | -1.94M | -1.88M | -1.88M | -1.80M |
| Total Depreciation and Amortization | 14.50K | -20.60K | 37.00K | 251.10K | 69.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 926.90K | 1.56M | 1.59M | 1.37M | 644.90K |
| Change in Net Operating Assets | 1.53M | -5.30K | -183.10K | -183.10K | 768.90K |
| Cash from Operations | 1.53M | -405.10K | -442.10K | -442.10K | -311.80K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | -- | 30.50K |
| Cash from Investing | -- | 0.00 | 0.00 | 0.00 | 30.50K |
| Total Debt Issued | 125.00K | 0.00 | 670.00K | 858.00K | 315.00K |
| Total Debt Repaid | -2.29M | -68.20K | -386.00K | -386.00K | -61.40K |
| Issuance of Common Stock | -- | 607.00K | 425.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -237.00K | -- | 237.00K |
| Cash from Financing | -1.56M | 395.10K | 345.00K | 345.00K | 363.90K |
| Foreign Exchange rate Adjustments | -1.50K | -500.00 | -3.30K | -3.30K | 2.70K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -34.40K | -10.50K | -100.50K | -100.50K | 85.30K |